Episode 6 – A/Prof Christopher J Sweeney

The Talking Urology team discuss the Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer (CHAARTED6) trial with lead author Christopher Sweeney, who is a Medical Oncologist at the Dana-Farber Cancer Institute, Boston, USA.

His primary research interest is drug discovery and development with an academic focus on the management of genitourinary malignancies, in particular prostate and testicular cancer.

Proudly supported by IPSEN IPSEN

Comments are closed.